BioWorld MedTech

Feb. 10, 2014

Funding Challenges Explored: Series B round becoming the new A round as early stage funding thins

In 2012, during a panel at the Southeastern Medical Device Association (SEMDA; Norcross, Georgia) med-tech serial entrepreneur Jerry Gibson uttered the unforgettable phrase that today's "A-round funding is yesterday's B-round funding." Read More

A Latin American Med-Tech Primer: Risk and reward mark Latin America's 6 largest device markets

Financings roundup: Ekso Bionics raises $30.3M in alternative funding offering

Washington Roundup: Nano-forum participants see gaps in transition from R&D to market

Patent Watch: Hygenix awarded patent for hand washing wristband technology

Court Report: Merck to pay $100 million to settle NuvaRing lawsuits

International Report: Gore launches new Excluder in Australia

People in Places

Product Briefs

Briefly Noted

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for March 27, 2026.

Emerging therapeutic strategies for Parkinson’s at ADPD 2026

BioWorld

Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...

Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

Small-molecule TREM2 agonist advances to treat Alzheimer’s

BioWorld Science

Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...

With improved technologies, biomarkers, failed drugs may come into their own

BioWorld

At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 24, 2026